Matthew Davis

Matthew Davis

Corporate Officer/Principal at AQUESTIVE THERAPEUTICS, INC.

Net worth: 402 000 $ as of 31/05/2026

Health Technology
Consumer Services
Consumer Non-Durables

Profile

Matthew W.
Davis
is currently an Adjunct Associate Professor at Temple University (Pennsylvania) since 2012.
He is the Chief Operating & Medical Officer at Tiziana Life Sciences Ltd. (United Kingdom) starting in 2022.
He will be the Chief Development Officer at Aquestive Therapeutics, Inc. beginning in 2025.
Formerly, Dr. Davis was SVP-Research & Development Branded Pharmaceuticals at Endo International Plc, Head-Medical Affairs & Pharmacovigilance at Endo Pharmaceuticals, Inc., Head-Medical Affairs at Dermik Laboratories, Inc., Vice President-Branded Products & Medical Affairs at URL Pharma, Inc., Head-Clinical Development & Medical Affairs at Dr. Reddy's Laboratories, Inc., Chief Medical Officer at Lupin, Inc., and Chief Operating & Medical Officer at Tiziana Life Sciences Ltd. from 2022 to 2024.
Education includes a doctorate from Drexel University College of Medicine and an undergraduate degree from Temple University School of Pharmacy.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
09/03/2026 100,000 ( 0.08% ) 402 000 $ 31/05/2026

Matthew Davis active positions

CompaniesPositionStart
AQUESTIVE THERAPEUTICS, INC. Corporate Officer/Principal 04/11/2025
Corporate Officer/Principal -
Chief Operating Officer -

Former positions of Matthew Davis

CompaniesPositionEnd
TIZIANA LIFE SCIENCES LTD Chief Operating Officer 01/07/2024
Chief Tech/Sci/R&D Officer -
ENDO INTERNATIONAL PLC Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Matthew Davis's experience

Training of Matthew Davis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

41

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Non-Durables

Health Technology

Health Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!